“The global tumor ablation market is poised to grow at a CAGR of 11.5% during the forecast period (2015-2020), and is expected to reach a value of ~515.2 million by 2020. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the tumor ablation market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period. Growth in the tumor ablation market is driven by factors such as growing geriatric population across the world, increasing population base for cancer patients, technological advancements in ablation devices, increasing number of hospitals and surgical and ablation centers, and growing awareness regarding the benefits offered by ablation procedures over those of conventional therapeutic and surgical procedures. However, factors such as cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are restraining the growth of this market. In addition, therapeutic challenges related to ablation procedures and stringent regulatory guidelines leading to significant increase in gestation period of product launches are posing significant challenges for the growth of the tumor ablation market.
In this report, the global tumor ablation market is segmented on the basis of technology (radiofrequency ablation, microwave ablation, cryoablation, and other technologies), mode of treatment (surgical, laparoscopic, and percutaneous ablation), and application (liver cancer, lung cancer, kidney cancer, bone metastasis, and other applications). The radiofrequency ablation technology segment accounted for the largest share of the global tumor ablation market in 2014, followed by the microwave ablation technology market. Factors such as significant awareness in the medical community about the application of radiofrequency ablation in cancer treatments, presence of a large number of radiofrequency ablation centers across the globe, and low procedural costs associated with radiofrequency tumor ablation are driving the growth of the radiofrequency tumor ablation market.
Geographically, North America (comprising the U.S. and Canada) commands the largest share of the global tumor ablation market in 2014, followed by Europe. The tumor ablation market in North America is primarily driven by factors such as early introduction and high adoption rate of tumor ablation products in the region, significant trend of replacing older technologies with advanced and innovative therapeutic techniques (such as microwave ablation and cryoablation), and increasing private/public funding to develop and commercialize novel tumor ablation products. However, financial constraints faced by market players are limiting the growth of the tumor ablation market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years, owing to factors such as large population base paired with high prevalence of various cancers (such as liver, lung, and kidney) in the region, ongoing government initiatives for development and modernization of healthcare infrastructure, increasing adoption due to continuously decreasing prices of tumor ablation products, and rising trends related to localized manufacturing due to growing focus of global giants in the APAC market.
The global tumor ablation market is moderately competitive with various global as well as local market players. As of 2014, the global tumor ablation market was dominated by Medtronic, plc (U.S.), AngioDynamics, Inc. (U.S.), HealthTronics, Inc. (U.S.), Galil Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.) that together accounted for ~83.0% of the market. New product launches; partnerships, agreements, and collaborations; and strategic acquisitions are the major strategies adopted by most of the market players to achieve growth in the global tumor ablation market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis such as industry analysis (industry trends and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the tumor ablation market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helped firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on tumor ablation products offered by the top 10 players in the global tumor ablation market. The report analyzes the tumor ablation market by technology, mode of treatment, and application across key geographic regions
• Product Development/Innovation: Detailed insights on upcoming tumor ablation technologies, research and development activities, and new product launches in the global tumor ablation market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various tumor ablation products across key geographic regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global tumor ablation market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global tumor ablation market
”
“TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.2 MARKET SIZE ESTIMATION
2.2.1 TOP-DOWN APPROACH
2.2.2 BOTTOM-UP APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT MARKET SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 MARKET OPPORTUNITIES FOR GROWTH IN TUMOR ABLATION MARKET (2015-2020)
4.2 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF TUMOR ABLATION MARKET FOR SURGICAL MODE OF TREATMENT, IN 2015
4.3 CHINA AND INDIA TO LEAD THE MARKET GROWTH FOR TUMOR ABLATION TECHNOLOGIES DURING THE FORECAST PERIOD
4.4 CHINA AND INDIA TO LEAD THE MARKET DEMAND FOR MICROWAVE AND CRYOABLATION-BASED TUMOR ABLATION PRODUCTS
4.5 NORTH AMERICA TO HOLD THE LARGEST SHARE OF LIVER CANCER ABLATION MARKET IN 2015
4.6 MEDTRONIC, PLC DOMINATED THE TUMOR ABLATION MARKET IN 2014
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET EVOLUTION
5.4 MARKET DYNAMICS
5.4.1 OVERVIEW
5.4.2 IMPACT ANALYSIS
5.4.3 KEY MARKET DRIVERS
5.4.3.1 GROWING GERIATRIC POPULATION ACROSS THE GLOBE
5.4.3.2 INCREASING POPULATION OF CANCER PATIENTS
5.4.3.3 CONTINUOUS TECHNOLOGICAL ADVANCEMENTS IN TUMOR ABLATION PRODUCTS
5.4.3.4 INCREASING NUMBER OF HOSPITALS, AND SURGICAL AND ABLATION CENTERS
5.4.4 KEY MARKET RESTRAINTS
5.4.4.1 COST CONTAINMENT MEASURES TAKEN BY VARIOUS GOVERNMENTS
5.4.4.2 ONGOING HEALTHCARE REFORMS IN THE U.S.
5.4.5 KEY MARKET OPPORTUNITIES
5.4.5.1 EMERGING MARKETS
5.4.5.2 GROWING AWARENESS OF ABLATION PROCEDURES
5.4.5.3 CHANGING REIMBURSEMENT LANDSCAPE
5.4.6 KEY MARKET CHALLENGES
5.4.6.1 STRINGENT REGULATORY GUIDELINES
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 INDUSTRY TRENDS
6.3.1 GROWING ADOPTION RATE OF RADIOFREQUENCY-BASED TUMOR ABLATION PROCEDURES
6.3.2 GROWING MARKET FOCUS ON THE DEVELOPMENT OF NOVEL MICROWAVE-BASED TUMOR ABLATION PRODUCTS
6.4 PORTER’S FIVE FORCE ANALYSIS
6.4.1 OVERVIEW
6.4.2 THREAT FROM NEW ENTRANTS
6.4.3 THREAT OF SUBSTITUTES
6.4.4 BARGAINING POWER OF SUPPLIERS
6.4.5 BARGAINING POWER OF BUYERS
6.4.6 INTENSITY OF COMPETITIVE RIVALRY
7 TUMOR ABLATION MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 RADIOFREQUENCY (RF) ABLATION
7.3 MICROWAVE ABLATION
7.4 CRYOABLATION
7.5 OTHER TECHNOLOGIES
8 TUMOR ABLATION MARKET, BY MODE OF TREATMENT
8.1 INTRODUCTION
8.2 SURGICAL ABLATION
8.3 LAPAROSCOPIC ABLATION
8.4 PERCUTANEOUS ABLATION
9 TUMOR ABLATION MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 LIVER CANCER ABLATION
9.3 LUNG CANCER ABLATION
9.4 KIDNEY CANCER ABLATION
9.5 BONE METASTASIS ABLATION
9.6 OTHER APPLICATIONS
10 TUMOR ABLATION MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 ITALY
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 U.K.
10.3.5 SPAIN
10.3.6 REST OF EUROPE (ROE)
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA-PACIFIC (ROAPAC)
10.5 REST OF THE WORLD (ROW)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SCENARIO
11.4 RECENT DEVELOPMENTS
11.4.1 PIPELINE DEVELOPMENTS AND PRODUCT ENHANCEMENTS
11.4.2 DIVESTMENTS AND ACQUISITIONS
11.4.3 GEOGRAPHIC EXPANSION
11.4.4 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
11.4.5 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 INTRODUCTION
12.1.1 GEOGRAPHIC BENCHMARKING
12.1.2 KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
12.2 MEDTRONIC, PLC (U.S.)
12.3 ANGIODYNAMICS, INC. (U.S.)
12.4 HEALTHTRONICS, INC. (U.S.)
12.5 GALIL MEDICAL, INC. (U.S.)
12.6 BOSTON SCIENTIFIC CORPORATION (U.S.)
12.7 NEUWAVE MEDICAL, INC. (U.S.)
12.8 EDAP TMS S.A. (FRANCE)
12.9 MERMAID MEDICAL, INC. (DENMARK)
12.10 SONACARE MEDICAL, LLC (U.S.)
12.11 MESONIX, INC. (U.S.)
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.3.1 VALUE CHAIN
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
“
“LIST OF TABLES
TABLE – 1 GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
TABLE – 2 TUMOR ABLATION MARKET SIZE FOR RF ABLATION TECHNOLOGY, BY REGION, 2013–2020 ($MILLION)
TABLE – 3 TUMOR ABLATION MARKET SIZE FOR MICROWAVE ABLATION TECHNOLOGY, BY REGION, 2013–2020 ($MILLION)
TABLE – 4 TUMOR ABLATION MARKET SIZE FOR CRYOABLATION TECHNOLOGY, BY REGION, 2013–2020 ($MILLION)
TABLE – 5 TUMOR ABLATION MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION,
2013–2020 ($MILLION)
TABLE – 6 GLOBAL TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 7 CLINICAL PERSPECTIVE OF KEY HEPATOCELLULAR CARCINOMA SURGICAL TREATMENT MODES – A COMPARATIVE STUDY
TABLE – 8 TUMOR ABLATION MARKET SIZE FOR SURGICAL MODE OF TREATMENT,
BY REGION, 2013–2020 ($MILLION)
TABLE – 9 TUMOR ABLATION MARKET SIZE FOR LAPAROSCOPIC MODE OF TREATMENT,
BY REGION, 2013–2020 ($MILLION)
TABLE – 10 TUMOR ABLATION MARKET SIZE FOR PERCUTANEOUS MODE OF TREATMENT,
BY REGION, 2013–2020 ($MILLION)
TABLE – 11 KEY PERCUTANEOUS TUMOR ABLATION TECHNOLOGIES – A COMPARATIVE STUDY
TABLE – 12 GLOBAL TUMOR ABLATION MARKET SIZE, BY APPLICATION,
2013–2020 ($MILLION)
TABLE – 13 TUMOR ABLATION MARKET SIZE FOR LIVER CANCER APPLICATION, BY REGION, 2013–2020 ($MILLION)
TABLE – 14 LIVER CANCER ABLATION MARKET—INFLUENCING FACTORS
TABLE – 15 TUMOR ABLATION MARKET SIZE FOR LUNG CANCER APPLICATION, BY REGION, 2013–2020 ($MILLION)
TABLE – 16 LUNG CANCER ABLATION MARKET—INFLUENCING FACTORS
TABLE – 17 TUMOR ABLATION MARKET SIZE FOR KIDNEY CANCER APPLICATION, BY REGION, 2013–2020 ($MILLION)
TABLE – 18 KIDNEY CANCER ABLATION MARKET—INFLUENCING FACTORS
TABLE – 19 TUMOR ABLATION MARKET SIZE FOR BONE METASTASIS APPLICATION,
BY REGION, 2013–2020 ($MILLION)
TABLE – 20 BONE METASTASIS ABLATION MARKET—INFLUENCING FACTORS
TABLE – 21 TUMOR ABLATION MARKET SIZE FOR OTHER APPLICATIONS, BY REGION,
2013–2020 ($MILLION)
TABLE – 22 GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
TABLE – 23 NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION)
TABLE – 24 NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY,
2013-2020 ($MILLION)
TABLE – 25 NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
TABLE – 26 NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION)
TABLE – 27 U.S.: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE – 28 U.S.: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 29 U.S.: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 30 CANADA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE – 31 CANADA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 32 CANADA: TUMOR ABLATION MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION)
TABLE – 33 EUROPE: TUMOR ABLATION MARKET SIZE, BY COUNTRY/REGION,
2013-2020 ($MILLION)
TABLE – 34 EUROPE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY,
2013-2020 ($MILLION)
TABLE – 35 EUROPE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 36 EUROPE: TUMOR ABLATION MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION)
TABLE – 37 ITALY: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE – 38 ITALY: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
TABLE – 39 ITALY: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 40 GERMANY: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE – 41 GERMANY: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 42 GERMANY: TUMOR ABLATION MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION)
TABLE – 43 FRANCE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION)
TABLE – 44 FRANCE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 45 FRANCE: TUMOR ABLATION MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION)
TABLE – 46 U.K.: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
TABLE – 47 U.K.: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 48 U.K.: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 49 SPAIN: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY,
2013–2020 ($MILLION)
TABLE – 50 SPAIN: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 51 SPAIN: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 52 ROE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
TABLE – 53 ROE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 54 ROE: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 55 ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY COUNTRY/REGION,
2013-2020 ($MILLION)
TABLE – 56 ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY,
2013-2020 ($MILLION)
TABLE – 57 ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 58 ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION)
TABLE – 59 JAPAN: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY,
2013-2020 ($MILLION)
TABLE – 60 JAPAN: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 61 JAPAN: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 62 CHINA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE – 63 CHINA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 64 CHINA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 65 INDIA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE – 66 INDIA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 67 INDIA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 68 ROAPAC: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE – 69 ROAPAC: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 70 ROAPAC: TUMOR ABLATION MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION)
TABLE – 71 ROW: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE – 72 ROW: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT,
2013-2020 ($MILLION)
TABLE – 73 ROW: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
TABLE – 74 PIPELINE DEVELOPMENTS AND PRODUCT ENHANCEMENTS (2012-2015)
TABLE – 75 DIVESTMENTS AND ACQUISITIONS (2012-2015)
TABLE – 76 GEOGRAPHIC EXPANSIONS (2012-2015)
TABLE – 77 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2012-2015)
TABLE – 78 OTHER DEVELOPMENTS (2012-2015)
“
“LIST OF FIGURES
FIGURE-1 RESEARCH DATA
FIGURE-2 MARKET SIZE ESTIMATION
FIGURE-3 TUMOR ABLATION MARKET , BY COUNTRY/REGION (2015–2020)
FIGURE-4 TUMOR ABLATION MARKET: REGIONAL SCENARIO (2015)
FIGURE-5 GLOBAL TUMOR ABLATION MARKET FUTURE TRENDS, BY MODE OF TREATMENT AND APPLICATION (2015–2020)
FIGURE-6 MARKET EVOLUTION
FIGURE-7 KEY TUMOR ABLATION MARKETS: CHANGING PROPORTION OF GERIATRIC INDIVIDUALS IN TOTAL POPULATION (2012 VS. 2020)
FIGURE-8 GLOBAL PREVALENCE OF CANCER: EXPECTED TREND TILL 2020
FIGURE-9 PERCENTAGE CHANGE IN HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING NATIONS (2010–2012)
FIGURE-10 VALUE CHAIN ANALYSIS
FIGURE-11 TUMOR ABLATION MARKET, BY TECHNOLOGY: GROWTH FORECAST DURING
2015–2020
FIGURE-12 TUMOR ABLATION MARKET SHARE FOR RF TECHNOLOGY, BY REGION (2015)
FIGURE-13 TUMOR ABLATION MARKET SHARE FOR MICROWAVE TECHNOLOGY, BY REGION (2015)
FIGURE-14 TUMOR ABLATION MARKET SHARE FOR CRYOABLATION TECHNOLOGY, BY REGION (2015)
FIGURE-15 TUMOR ABLATION MARKET SHARE FOR OTHER TECHNOLOGIES, BY REGION (2015)
FIGURE-16 TUMOR ABLATION MARKET, BY APPLICATION: GROWTH FORECAST DURING
2015-2020
FIGURE-17 TUMOR ABLATION MARKET FOR SURGICAL MODE OF TREATMENT, BY REGION (2015)
FIGURE-18 TUMOR ABLATION MARKET FOR LAPAROSCOPIC MODE, BY REGION (2015)
FIGURE-19 TUMOR ABLATION MARKET FOR PERCUTANEOUS MODE, BY REGION (2015)
FIGURE-20 TUMOR ABLATION MARKET, BY APPLICATION: GROWTH FORECAST DURING 2015-2020
FIGURE-21 TUMOR ABLATION MARKET SHARE FOR LIVER CANCER, BY REGION (2015)
FIGURE-22 TUMOR ABLATION MARKET SHARE FOR LUNG CANCER, BY REGION (2015)
FIGURE-23 TUMOR ABLATION MARKET SHARE FOR KIDNEY CANCER, BY REGION (2015)
FIGURE-24 TUMOR ABLATION MARKET SHARE FOR BONE METASTASIS, BY REGION (2015)
FIGURE-25 TUMOR ABLATION MARKET SHARE FOR OTHER APPLICATIONS, BY REGION (2015)
FIGURE-26 NORTH AMERICA: TUMOR ABLATION MARKET, EXPECTED TREND (2015 VS. 2020)
FIGURE-27 NORTH AMERICA: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY, 2015
FIGURE-28 U.S.: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-29 U.S.: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-30 U.S.: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-31 CANADA: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-32 CANADA: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-33 CANADA: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-34 EUROPE: TUMOR ABLATION MARKET, EXPECTED TREND (2015 VS. 2020)
FIGURE-35 EU-5: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY, 2015
FIGURE-36 ITALY: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-37 ITALY: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-38 ITALY: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-39 GERMANY: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-40 GERMANY: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-41 GERMANY: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-42 FRANCE: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-43 FRANCE: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-44 FRANCE: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-45 U.K.: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-46 U.K.: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-47 U.K.: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-48 SPAIN: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-49 SPAIN: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-50 SPAIN: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-51 ROE: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-52 ROE: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-53 ROE: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-54 ASIA-PACIFIC: TUMOR ABLATION MARKET, EXPECTED TREND (2015 VS. 2020)
FIGURE-55 ASIA-PACIFIC: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY, 2015
FIGURE-56 JAPAN: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-57 JAPAN: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-58 JAPAN: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-59 CHINA: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-60 CHINA: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-61 CHINA: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-62 INDIA: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-63 INDIA: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-64 INDIA: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-65 ROAPAC: TUMOR ABLATION MARKET SHARE, BY TECHNOLOGY (2015)
FIGURE-66 ROAPAC: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
FIGURE-67 ROAPAC: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
FIGURE-68 ROW: TUMOR ABLATION MARKET, EXPECTED TREND (2015 VS. 2020)
FIGURE-69 LEADING MARKET PLAYERS ADOPTED PRODUCT DEVELOPMENT AND COMMERCIALIZATION AS KEY GROWTH STRATEGIES DURING 2012-2015
FIGURE-70 TUMOR ABLATION MARKET SHARE, BY KEY PLAYER (2014)
FIGURE-71 KEY GROWTH STRATEGIES, BY YEAR
FIGURE-72 PRODUCT DEVELOPMENT, THE MOST WIDELY ADOPTED GROWTH STRATEGY DURING 2012-2015
FIGURE-73 TOP 5 PLAYERS GENERATED MORE THAN 3/5TH OF THEIR GLOBAL TUMOR ABLATION REVENUE FROM AMERICAS *
FIGURE-74 TECHNOLOGICAL DEVELOPMENT AND PRODUCT ENHANCEMENT IS THE KEY STRATEGY PURSUED BY TOP PLAYERS TOINCREASE THEIR TUMOR ABLATION MARKET REVENUE
“
